BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 17208308)

  • 1. Immunohistochemical expression of epidermal growth factor receptor and cyclooxygenase-2 in pediatric nasopharyngeal carcinomas: no significant correlations with clinicopathological variables and treatment outcomes.
    Fang FM; Li CF; Chien CY; Rau KM; Huang HY
    Int J Pediatr Otorhinolaryngol; 2007 Mar; 71(3):447-55. PubMed ID: 17208308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy.
    Chua DT; Nicholls JM; Sham JS; Au GK
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):11-20. PubMed ID: 15093894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of tumor angiogenesis, Ki 67, p53 oncoprotein, epidermal growth factor receptor and HER2 receptor protein expression in undifferentiated nasopharyngeal carcinoma--a prospective study.
    Ma BB; Poon TC; To KF; Zee B; Mo FK; Chan CM; Ho S; Teo PM; Johnson PJ; Chan AT
    Head Neck; 2003 Oct; 25(10):864-72. PubMed ID: 12966511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma.
    Ang KK; Berkey BA; Tu X; Zhang HZ; Katz R; Hammond EH; Fu KK; Milas L
    Cancer Res; 2002 Dec; 62(24):7350-6. PubMed ID: 12499279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of poor survival by cyclooxygenase-2 in patients with T4 nasopharyngeal cancer treated by radiation therapy: clinical and in vitro studies.
    Chen WC; McBride WH; Chen SM; Lee KF; Hwang TZ; Jung SM; Shau H; Liao SK; Hong JH; Chen MF
    Head Neck; 2005 Jun; 27(6):503-12. PubMed ID: 15772955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlations between expression of epidermal growth factor receptor (EGFR), phosphorylated EGFR, cyclooxygenase-2 and clinicopathological variables and treatment outcomes in nasopharyngeal carcinomas.
    Huang TL; Li CF; Huang HY; Fang FM
    Chang Gung Med J; 2010; 33(6):619-27. PubMed ID: 21199607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of HER2neu (c-erbB-2) and epidermal growth factor receptor in cervical cancer: prognostic correlation with clinical characteristics, and comparison of manual and automated imaging analysis.
    Lee CM; Lee RJ; Hammond E; Tsodikov A; Dodson M; Zempolich K; Gaffney DK
    Gynecol Oncol; 2004 Apr; 93(1):209-14. PubMed ID: 15047238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological markers and prognosis in recurrent oral cancer after salvage surgery.
    Agra IM; Carvalho AL; Pinto CA; Martins EP; Filho JG; Soares FA; Kowalski LP
    Arch Otolaryngol Head Neck Surg; 2008 Jul; 134(7):743-9. PubMed ID: 18645125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical significance of coexpression of cyclooxygenases-2, vascular endothelial growth factors, and epidermal growth factor receptor in nasopharyngeal carcinoma.
    Pan J; Kong L; Lin S; Chen G; Chen Q; Lu JJ
    Laryngoscope; 2008 Nov; 118(11):1970-5. PubMed ID: 18758376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment outcomes for radiotherapy alone are comparable with neoadjuvant chemotherapy followed by radiotherapy in early-stage nasopharyngeal carcinoma.
    Song CH; Wu HG; Heo DS; Kim KH; Sung MW; Park CI
    Laryngoscope; 2008 Apr; 118(4):663-70. PubMed ID: 18216741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
    Wang KL; Wu TT; Choi IS; Wang H; Resetkova E; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Albarracin CT
    Cancer; 2007 Feb; 109(4):658-67. PubMed ID: 17211865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of hemoglobin concentration in nasopharyngeal carcinoma: does treatment-induced anemia have negative effect?
    Altun M; Demiral AN; Meral R; Kaytan E; Cosar R; Disci R; Dizdar Y
    In Vivo; 2003; 17(5):483-7. PubMed ID: 14598613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlation of DNA ploidy in fresh tumor tissues to prognosis of nasopharyngeal carcinoma].
    Han F; Wang HY; Xia YF; Liu MZ; Zhao C; Lu TX
    Ai Zheng; 2007 Sep; 26(9):1015-9. PubMed ID: 17927864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum lactate dehydrogenase level is a prognostic factor in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy.
    Turen S; Ozyar E; Altundag K; Gullu I; Atahan IL
    Cancer Invest; 2007 Aug; 25(5):315-21. PubMed ID: 17661206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of cyclooxygenase-2 in nasopharyngeal carcinoma and association with epidermal growth factor receptor expression.
    Soo R; Putti T; Tao Q; Goh BC; Lee KH; Kwok-Seng L; Tan L; Hsieh WS
    Arch Otolaryngol Head Neck Surg; 2005 Feb; 131(2):147-52. PubMed ID: 15723947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the prognostic role of a panel of biomarkers in stage IB-IIIA non-small cell lung cancer patients.
    Timotheadou E; Skarlos DV; Samantas E; Papadopoulos S; Murray S; Skrickova J; Christodoulou C; Papakostantinou C; Pectasides D; Papakostas P; Kaplanova J; Vrettou E; Karina M; Kosmidis P; Fountzilas G
    Anticancer Res; 2007; 27(6C):4481-9. PubMed ID: 18214064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Correlation of endothelin A receptor expression to prognosis of nasopharyngeal carcinoma].
    Mai HQ; Zeng ZY; Zhang HZ; Hou JH; Mo HY; Guo X; Min HQ; Hong MH
    Ai Zheng; 2005 May; 24(5):611-5. PubMed ID: 15890108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COX-2 expression in hepatocellular carcinoma is an initiation event; while EGF receptor expression with downstream pathway activation is a prognostic predictor of survival.
    Foster J; Black J; LeVea C; Khoury T; Kuvshinoff B; Javle M; Gibbs JF
    Ann Surg Oncol; 2007 Feb; 14(2):752-8. PubMed ID: 17146741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclooxygenase-2 and epidermal growth factor receptor expressions in different histological subtypes of cervical carcinomas.
    Baltazar F; Filho AL; Pinheiro C; Moreira MA; Queiroz GS; Oton GJ; JĂșnior AF; Ribeiro LF; Schmitt FC
    Int J Gynecol Pathol; 2007 Jul; 26(3):235-41. PubMed ID: 17581404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal growth factor receptor signaling in adenocarcinomas with bronchioloalveolar components.
    Sarkaria IS; Zakowski MF; Pham D; Hezel M; Ebright MI; Chuai S; Venkatraman ES; Kris MG; Rusch VW; Singh B
    Ann Thorac Surg; 2008 Jan; 85(1):216-23. PubMed ID: 18154814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.